News

Novexel has initiated Phase II clinical trial for advanced oral antibacterial NXL103 (flopristin/linopristin) in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is designed

The House of Representatives has approved new and stringent standards for chemical site security, pushing forth with efforts to mandate product substitution in a misguided attempt to safeguard

Boston Scientific has reached an agreement, in principle, with the US Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged

Xoma has expanded its development strategy for its XOMA 052 antibody to interleukin-1 beta (IL-1 beta) to include effects on cholesterol lowering, reducing plaque deposits and damage to

Calbiotech has received a Small Business Innovative Research (SBIR) Phase I contract by the US Army Medical Research and Material command. Under terms of the agreement, Calbiotech is

Covidien has completed the previously announced acquisition of Aspect Medical Systems for an aggregate consideration of approximately $210m, net of cash and short-term investments acquired. The tender offer

Ziopharm has presented positive interim data from the multicenter randomized Phase II trial of palifosfamide (Zymafos, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The randomized

Sagentia, a part of a consortium led by GlaxoSmithKline, is delivering a step change improvement in advanced secondary pharmaceutical manufacturing in the UK. The aim of the project

The endorsement comes less than a year after the vaccine’s first licensure and will accelerate global access to Synflorix. Jean Stephenne, CEO of GSK, said: “The vaccine helps